Clinical trial
Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine…
NCT00193908 · Trans Tasman Radiation Oncology Group, Other · Completed
Key facts
| NCT number | NCT00193908 |
|---|---|
| Title | Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream |
| Official title | A Paired Double Blind Randomised Comparison of Cavilon(TM) Durable Barrier Cream(TM)[CDBC] to 10% Glycerine ("Sorbolene") Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care |
| Lead sponsor | Trans Tasman Radiation Oncology Group, Other |
| Collaborators | 3M Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Cavilon (TM) Durable Barrier Cream, Sorbolene, Radiotherapy |
| Enrollment | 333 |
| Start date | Mar 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Oct 1, 2008 |
| First posted | Sep 19, 2005 |
| Last update posted | May 14, 2009 |
| Countries | Australia |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: